UnicoCell Biomed Co., Ltd. (6794.TW)
TWD 70.8
(0.28%)
TWD 70.8
(0.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -65.54 Million | -63.6 Million | -61.7 Million | -92.15 Million | -77.17 Million |
| Net Income | -84.1 Million | -91.15 Million | -86.37 Million | -109.2 Million | -100.93 Million |
| Depreciation & Amortization | 26.38 Million | 24.27 Million | 26.27 Million | 23.66 Million | 20.61 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 1.81 Million | 2.96 Million | 2.26 Million | 3.04 Million | 2.27 Million |
| Change in working capital | -1.39 Million | 391 Thousand | -4.15 Million | -9.36 Million | -555 Thousand |
| Other non-cash items | -4.36 Million | 375 Thousand | 455 Thousand | 445 Thousand | 1.43 Million |
| Investing Cash Flow | -307.2 Million | -164.98 Million | -23.8 Million | -57.11 Million | -50.37 Million |
| Investments in PPE | -15.98 Million | -14.6 Million | -23.99 Million | -56.84 Million | -50.76 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -297.13 Million | -150.07 Million | -76 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -239 Thousand | -301 Thousand | 268 Thousand | -269 Thousand | 395 Thousand |
| Financing Cash Flow | 339 Million | 151.37 Million | -5.65 Million | 145.44 Million | 110.39 Million |
| Debt repayment | -6.04 Million | - | - | - | -9.6 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 344.87 Million | 159.04 Million | 3.69 Million | 155.25 Million | - |
| Other Financing Activities | 170 Thousand | 150 Thousand | 19 Thousand | - | 120 Million |
| Accounts receivables | -1.02 Million | - | - | - | 451 Thousand |
| Accounts payables | - | - | - | - | - |
| Inventory | 723 Thousand | -65 Thousand | -2.09 Million | 51 Thousand | -1.6 Million |
| Other working capital | -1.09 Million | - | - | - | 598 Thousand |
| Cash at beginning of period | 53.63 Million | 130.85 Million | 222.01 Million | 225.85 Million | 252.96 Million |
| Cash at end of period | 19.89 Million | 53.63 Million | 130.85 Million | 222.01 Million | 218.91 Million |
| Capital Expenditure | -15.98 Million | -14.6 Million | -23.99 Million | -56.84 Million | -50.76 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -33.74 Million | -77.21 Million | -91.16 Million | -3.83 Million | -34.05 Million |
| Free Cash Flow | -81.52 Million | -78.21 Million | -85.7 Million | -149 Million | -127.93 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -25.95 Million | -31.51 Million | -84.1 Million | -25.54 Million | -25.54 Million | -15.56 Million |
| Depreciation & Amortization | 7.93 Million | 7.9 Million | 26.38 Million | 7.41 Million | 7.41 Million | 5.39 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 937 Thousand | 199 Thousand | 1.81 Million | 296 Thousand | 296 Thousand | 654 Thousand |
| Change in working capital | 3.13 Million | 2.23 Million | -1.39 Million | 918.5 Thousand | 918.5 Thousand | 5.1 Million |
| Other non-cash items | -1.27 Million | -1.06 Million | -4.36 Million | -1.94 Million | -1.94 Million | -1.41 Million |
| Investing Cash Flow | -145.68 Million | 17.22 Million | -307.2 Million | -1.19 Million | -1.19 Million | 44.16 Million |
| Investments in PPE | -1.79 Million | -139 Thousand | -15.98 Million | -5.61 Million | -5.61 Million | 24 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -143.88 Million | 17.01 Million | -297.13 Million | - | - | 43.84 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 3000.00 | 355 Thousand | -239 Thousand | 4.41 Million | 4.41 Million | 225 Thousand |
| Financing Cash Flow | 177.36 Million | -1.51 Million | 339 Million | 1.2 Million | 1.2 Million | -1.3 Million |
| Debt repayment | -1.51 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 179.1 Million | - | 344.87 Million | - | - | - |
| Other Financing Activities | 178.88 Million | - | 170 Thousand | 1.2 Million | 1.2 Million | - |
| Accounts receivables | 574 Thousand | - | - | -262.5 Thousand | -262.5 Thousand | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -191 Thousand | 469 Thousand | 723 Thousand | -137 Thousand | -137 Thousand | 718 Thousand |
| Other working capital | -662 Thousand | - | - | 1.31 Million | 1.31 Million | - |
| Cash at beginning of period | 15.76 Million | 19.89 Million | 53.63 Million | - | 57.59 Million | 19.66 Million |
| Cash at end of period | 33.11 Million | 15.76 Million | 19.89 Million | -18.84 Million | 38.74 Million | 57.59 Million |
| Capital Expenditure | -1.79 Million | -139 Thousand | -15.98 Million | -5.61 Million | -5.61 Million | 24 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 17.34 Million | -4.13 Million | -33.74 Million | -18.84 Million | -18.84 Million | 37.92 Million |
| Free Cash Flow | -16.13 Million | -19.99 Million | -81.52 Million | -24.47 Million | -24.47 Million | -4.91 Million |
7607
MC
GRAT
USEA
UGP
MSP